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Hypertension and kidney disease in Asia
Tazeen H. Jafara,b
Purpose of review
Communicable diseases were traditionally the major cause
of public health concern in Asian countries, most of which
were less developed. With industrialization and associated
lifestyle changes during the past few decades, however,
noncommunicable diseases similar to those that affect
Western societies have emerged in Asian countries. The
purpose of the review was to examine recent evidence
about the burden and factors associated with hypertension
and chronic kidney disease (CKD) in Asian countries.
Recent findings
Hypertension has become one of the leading causes of
mortality in Asia. Although its prevalence continues to rise, it
remains under-diagnosed and under-treated. CKD is
becoming increasingly common mainly due to an increase in
risk factors such as high blood pressure, diabetes, and
obesity. Treatment of advanced CKD is overwhelmingly
burdensome in a resource poor environment. Barriers to
early detection of CKD in Asians include the fact that
equations to estimate the glomerular filtration rate have not
been validated in this population, and the uncertainty about
appropriate glomerular filtration rate cutoff values to define
CKD.
Summary
Concerted efforts are needed to develop and implement
cost-effective strategies for prevention and treatment of
hypertension and CKD in Asian countries. More research is
needed on these conditions in these populations.
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Introduction
Communicable diseases were in the past the main causes
of death worldwide and life expectancy was often limited
by uncontrolled epidemics. Improvement of sanitary
conditions and living conditions as well as medical
advances in terms of vaccination and antibiotics, how-
ever, have successfully reduced infant mortality and
deaths from infectious diseases. On the other hand,
adopting the lifestyle of industrialized nations – such
as decreased physical activity and increased intake of
dietary fats – have resulted in the emergence of non-
communicable diseases as major problems in developing
countries. Cardiovascular and kidney diseases, cancer,
diabetes, chronic pulmonary and mental diseases pose
an immense burden for health systems in both developed
as well as developing countries, many of which are in Asia
[1]. In 1990, for example, the leading causes of disease
burden were pneumonia, diarrheal diseases, and perinatal
conditions. It is predicted that by 2020 noncommunicable
disease will account for 80% of the global burden of
disease, causing seven out of every 10 deaths in devel-
oping countries [2,3].
Hypertension
Hypertension is one of the most important modifiable
risk factors for cardiovascular disease (CVD) and chronic
kidney disease (CKD) [4,5]. The prevalence of hyper-
tension in countries in the Asian region is rising [6], but
rates of awareness and adequate control of blood pressure
remain appallingly low [7]. National-level efforts to stem
the rising tide of hypertension are lacking in most Asian
countries.
Despite the publications of several hypertension treat-
ment guidelines, primary care practitioners continue to
grossly under-diagnose and under-treat hypertension [8].
It appears that Asians are especially susceptible to insulin
resistance, which may in part be due to past history of
under-nutrition or low birth weight [9]. The presence of
insulin resistance compounds the deleterious impact of
high blood pressure in a synergistic manner in this
vulnerable population, which is now facing an explosion
of diabetes in epidemic proportions [2,10]. Ominously,
other risk factors predisposing to CVD and CKD such as
tobacco use, dietary fat intake, and sedentary lifestyles
are also becoming widespread [11].
During the past two decades, China, the most populous
nation in the world, has witnessed a doubling of the
number of deaths attributed to chronic diseases, in
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particular hypertension. In the recently conducted
nationally representative China National Hypertension
Survey Epidemiology Follow-up Study [12] on 169 871
adult men and women, the single most important factor
identified in terms of magnitude of adjusted relative risk
as well as attributable risk of death was hypertension.
The prevalence of hypertension continues to rise in
China. In 1998, 24% of population aged 35–59 years
suffered from this condition – a 2.3% increase compared
with 1992–1994. Among hypertensive Chinese subjects,
42.6% were aware of their hypertension, 31.1% were
treated, and merely 6% were controlled [6].
Data from Indo-Asian countries suggest an even higher
burden of hypertension. Results from the National Health
Survey of Pakistan 1990–1994 indicate that about one-
third of the general population in Pakistan aged 40 years or
over suffered from high blood pressure. Moreover, 70% of
hypertensive patients were unaware of their condition, and
blood pressure control rates (3%) were dismal. In fact, the
vast majority of adults have never had their blood pressure
checked [7,13]. This is a reflection of the existing health-
care systems in developing countries that are sensitized
mainly towards providing acute, symptomatic treatment
for infectious diseases, and are not accustomed to provid-
ing preventive care for chronic diseases.
Knowledge regarding cardiovascular health issues,
including hypertension, is severely lacking in some Asian
countries. These gaps in knowledge coupled with high
illiteracy rates translate into inadequate preventive
healthcare practices [14]. Lack of hypertension screening
and control programs in these regions means that
mortality from this condition is only expected to escalate
further [6,7].
Risk factors for hypertension
Most of the rise in the prevalence of hypertension in
countries such as China, Thailand, India, Pakistan, and
other Asian countries can be explained by changes in
distributions of body-mass index (BMI). Saturated fat
intake, insulin resistance, and blood cholesterol levels
have also increased concomitantly [15,16].
This issue may be more complex as the downstream
adverse consequences at any given severity of risk factor
may be worse in Asian populations. For example, com-
pared with white children in the US, children in Pakistan
had higher blood pressure at any given BMI level (Fig. 1)
[17]. Evidence suggests that associations between BMI,
percentage of body fat, and health risks may differ in
Asian and Western populations [18]. It has been shown
that in order to identify subjects at high risk of CVD,
lower values for BMI and waist circumference should be
used for Asian patients than the conventional cutoff
values for Western subjects [19]. One proposed expla-
nation for these observed differences in magnitude of risk
among Asians is the effect of poverty and resultant
malnutrition during intrauterine and early childhood
years. There may, however, also be other unexplained
factors at work [20].
Chronic kidney disease: low glomerular
filtration rate
In parallel with the sky-rocketing prevalence of uncon-
trolled hypertension and diabetes in Asia, the burden of
CKD as defined by a decreased level of estimated glo-
merular filtration rate (GFR) or albuminuria is also
expected to rapidly escalate in this region.
Adverse outcomes of CKD include loss of kidney func-
tion, sometimes leading to kidney failure, and CVD.
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Figure 1 Body mass index (BMI) specific blood pressure levels in children in Pakistan versus white children in the US
Data are on 5374 South Asian children
aged 5–14 years included in the National
Health Survey of Pakistan (NHSP)
(1990–1994) and 3389 white children in
the US included in NHANES III (1988–
1994). BMI cutoff values are based on the
25th, 50th, 75th and 95th percentiles of
values in the NHSP data. SBP, systolic
blood pressure; DBP, diastolic blood
pressure. Reproduced with permission
from Jafar et al. [17].
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Unfortunately, CKD is under-diagnosed and under-trea-
ted [21,22]. This problem is compounded in developing
countries that have poorly developed and under-
resourced healthcare system infrastructure. To give a
concrete example, in Indo-Asian countries, the annual
cost of dialysis is about US$4000. Kidney transplantation
cost about US$5000, and post-transplant medications cost
$2000 annually. Compared with this, the average yearly
per-capita income is $279; 36% of the population earns
less than $105 per annum, and only 2.2% earn more than
$1000 [23]. These countries therefore simply cannot
afford to treat kidney failure. Mortality due to untreated
CKD, although not well documented and quantified, is
likely to be very high.
A recent cohort study [24] conducted over 12 years in
Thailand on 3499 employees of the Electric Generation
Authority suggested a steep rise in magnitude of CKD. In
this study, the prevalence of decreased kidney function,
defined as an estimated GFR less than 60 ml/min using
the Modification of Diet in Renal Disease (MDRD)
study equation, increased from 1.7% (95% confidence
interval [CI], 1.3–2.1) in 1985 to 6.8% (95% CI, 5.7–7.9)
in 1997. The prevalence of elevated serum creatinine
(> 1.49 mg/dl in men and > 1.13 mg/dl in women)
increased from 6.1% (95% CI, 5.3–6.9) to 16.9% (95%
CI, 15.3–18.5). National level data were recently col-
lected on serum creatinine levels during 2000 and 2001
on 15 540 Chinese adults aged 35–74 years. The overall
prevalence of reduced estimated GFR below 60 ml/min
by the MDRD study equation was 2.53% [25].
It is important to point out in this context that the MDRD
study and other serum-creatinine-based renal function
estimating equations may not perform well among
Asians. Data on 1166 adult subjects from the general
population in Karachi, Pakistan collected during 2004
suggest that the prevalence of reduced estimated
creatinine clearance (< 60 ml/min per 1.73 m2) was
21% in men and 30% in women aged 40 years or over
if the Cockcroft–Gault equation were used. Using an
MDRD equation estimated GFR cutoff value of 60 ml/
min per 1.73 m2, the prevalence of kidney disease was 9%
in men and 11% in women, respectively (Table 1) [26]. A
wide discrepancy in estimated disease prevalence is
therefore obtained depending on whether the Cock-
croft–Gault or the MDRD equation is used to estimate
renal function in these participants. Agreement among
GFR estimation equations and the measured GFR (or
creatinine clearance) has been reported to be suboptimal
in Asian populations [27,28]. A lower creatinine
excretion in Indo-Asian men and women (17.5 and
14.1 mg/kg per day, respectively) has been reported
compared with the expected values (19.0 and 16.3 mg/
kg per day; P < 0.002 and P < 0.001, respectively) in
their Caucasian counterparts [27]. This may be
explained by a lower body muscle mass and lower meat
intake in Indo-Asians compared with white Caucasians.
Improvements in the existing GFR estimation equations
taking into account these differences are therefore
needed for Asian populations.
Finally to complicate matters more, data from 610 young
India potential kidney donors (with presumed normal
kidney function) showed that the mean GFR values of
Indiansmeasuringusing99mTc-diethylenetriaminepenta-
acetic acid plasma clearance was 81.4  19.4 ml/min per
1.73 m2 – significantly lower than what has been reported
for their Western counterparts (109–125 ml/min per
1.73 m2 body surface area) [29]. This implies that even
the GFR thresholds used to define CKD derived from
Western subjects may need to be modified for Asian
populations. Alternatively, kidney disease may be far
more prevalent in this population than is currently
appreciated.
More research is therefore needed to define population
GFR norms, and to develop accurate renal function
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Table 1 The age-specific prevalence (95% confidence interval) of the reduced estimated glomerular filtration rate (GFR) in an Indo-
Asian populationa
Age n
Serum creatinine
(mg/dl) (SD)
Reduced Cockcroft–Gault
estimated GFR (%)b
Reduced MDRD
estimated GFR (%)c
Men
40–49 years 267 1.00 (0.2) 10.9 (7.8–15.1) 6.0 (3.7–9.5)
50–59 years 164 1.02 (0.2) 15.9 (11.0–22.0) 5.0 (2.5–9.3)
>60 years 132 1.05 (0.3) 50.7 (42.3–59.1) 19.7 (13.8–37.3)
>40 years 563 1.02 (0.2) 21.6 (18.5–25.2) 8.9 (6.8–11.5)
Women
40–49 years 295 0.75 (0.2) 14.3 (10.7–18.7) 6.1 (3.9–9.5)
50–59 years 171 0.85 (0.5) 29.2 (22.9–36.0) 9.9 (6.3–15.3)
> 60 years 137 0.87 (0.3) 65.7 (57.4–73.2) 21.2 (15.1–28.9)
> 40 years 603 0.80 (0.3) 30.2 (26.7–34.0) 10.6 (8.4–13.3)
aThe reduced estimated GFR was defined as less than 60 ml/min per 1.73 m2.
bThe Cockcroft–Gault estimated GFR was calculated as: (140  age)  (weight [kg]) / serum creatinine [mg/dl]  72(  0.85 if female), and
adjusted to body surface area of 1.73 m2.
cThe Modification of Diet in Renal Disease (MDRD) study estimated GFR was calculated as: 186  (serum creatinine [mg/dl])1.154 
(age)0.203(  0.742 if female).
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estimation equations applicable to Asian populations
from serum creatinine and other markers.
The general paucity of clinical trials conducted in indi-
genous Asian populations as well as lack of Asian subjects
in those conducted in the West raise similar concerns
about the applying these treatment targets and interven-
tions strategies to Asian populations.
Chronic kidney disease: albuminuria
The other prominent aspect of CKD – albuminuria –
also seems to be highly prevalent across Asia. This is not
unexpected given the increasing prevalence of diabetes
in this region. In the Microalbuminuria Prevalence Study
[30], the prevalence of macroalbuminuria was 18.8% and
microalbuminuria was 39.8% among 6800 hypertensive
diabetic adult patients from 10 Asian countries.
Although national-level general population data based on
sound sampling strategies are needed for accurate assess-
ment of burden of albuminuria and various stages of CKD
in Asian countries, available evidence suggests a very
high prevalence of CKD, and its risk factors in the Asian
Pacific region.
Risk factors for CKD
Studies suggest that the main risk factors associated with
CKD in the Asian populations include elevated blood
pressure, elevated blood glucose and cholesterol levels,
smoking, and high BMI [24,31,32,33,34]. Most of these
are similar to those identified in Western populations
[35,36]. The prevalence of CKD also appears to increase
with increase in age in Asian countries [31]. To a signifi-
cant extent this is due to the acquisition of the afore-
mentioned risk factors, which are also associated with
aging and often confound the association between age
and CKD [24].
An as yet unresolved issue that relates to the Asian
population is that of possible greater susceptibility of
CKD because of a higher background prevalence of low
birth weight or malnutrition [37–39]. A number of
regional and global efforts have led to an overall improve-
ment in the latter trends [40,41], and these efforts must
continue. On the other hand, conventional risk factors for
CKD are on the rise in Asia so programs that focus on
prevention of CKD targeting conventional modifiable
risk factors, including high blood pressure, diabetes,
cholesterol, tobacco cessation, reduction in intake of
saturated fats, and obesity, are urgently needed in
Asian countries.
Future direction for research in Asians
More research is needed in the Asian population, mainly
focusing on cost-effective strategies for early detection
and prevention of hypertension, and CKD. This would
include understanding the feasibility and efficacy of
screening programs. Efforts are needed to study normal
levels of GFR, and to develop and validate GFR esti-
mation equations from serum creatinine and other mar-
kers that are applicable in this population. Prospective,
well controlled studies are needed in the Asian popu-
lations to define appropriate target levels of risk factors,
including the optimal level of BMI, waist circumference,
cholesterol levels, blood pressure levels, and urine albu-
min excretion for prevention of morbidity and mortality
from hypertension and CKD.
Conclusion
Hypertension is one the leading causes of mortality in Asia.
Despite rising prevalence it remains under-diagnosed and
under-treated. CKD is becoming increasingly common
mainly due to an increase in conventional risk factors
including high blood pressure, diabetes, and obesity. Early
detection of CKD in Asians is challenging as equations to
estimate GFR have not been validated in this population.
It is clear that well designed, cost-effective programs
are needed to control hypertension and CKD, targeting
their risk factors. These should include multiple strat-
egies for primary and secondary prevention. Efforts
need to be made to integrate these programs into the
existing healthcare infrastructure for ensuring long-term
sustainability.
Public education about adoption of healthy lifestyles
must be one of the essential aims of such programs. It
must, however, be coupled with appropriate public policy
interventions that ensure affordability and access of such
choices (e.g. antitobacco legislation and ban on sale of
saturated oil), especially in countries where literacy rates
are poor [11]. Cheap and reliable screening tests need to
be used for population screening. Industry support is
desired for subsidization of cost of effective medications,
which are necessary for many high-risk individuals [42].
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